“Out of the total 146 candidate vaccines, 27 are at the first clinical trial phase, 14 – at the second phase, while 9 – at the third phase”, said today chairman of Management Board of the Administration of Regional Medical Divisions (TABIB) Ramin Bayramli
at the meeting dedicated to issues of vaccination against SARS-COV-2 of Public Supervision Board of the Fund for Support to Fight against Coronavirus, APA reports.
R. Bayramli said the areas of production of vaccines in our country and purchase of vaccines from abroad are discussed.